The solubility–permeability interplay and oral drug formulation design: Two heads are better than one

A Dahan, A Beig, D Lindley, JM Miller - Advanced drug delivery reviews, 2016 - Elsevier
Poor aqueous solubility is a major challenge in today's biopharmaceutics. While solubility-
enabling formulations can significantly increase the apparent solubility of the drug, the …
被引用次数：183 相关文章

The solubility–permeability interplay and oral drug formulation design: Two heads are better than one

A Dahan, A Beig, D Lindley, JM Miller - Advanced Drug Delivery Reviews, 2016 - infona.pl
Poor aqueous solubility is a major challenge in today's biopharmaceutics. While solubility-
enabling formulations can significantly increase the apparent solubility of the drug, the …

The solubility–permeability interplay and oral drug formulation design: Two heads are better than one

A Dahan, A Beig, D Lindley, JM Miller - Advanced Drug Delivery …, 2016 - cris.bgu.ac.il
Poor aqueous solubility is a major challenge in today's biopharmaceutics. While solubility-
enabling formulations can significantly increase the apparent solubility of the drug, the …

[引用][C] The solubility–permeability interplay and oral drug formulation design: Two heads are better than one

A Dahan, A Beig, D Lindley, JM Miller - Advanced Drug Delivery …, 2016 - cir.nii.ac.jp
The solubility–permeability interplay and oral drug formulation design: Two heads are better
than one | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

The solubility-permeability interplay and oral drug formulation design: Two heads are better than one

A Dahan, A Beig, D Lindley… - Advanced drug delivery …, 2016 - pubmed.ncbi.nlm.nih.gov
Poor aqueous solubility is a major challenge in today's biopharmaceutics. While solubility-
enabling formulations can significantly increase the apparent solubility of the drug, the …

The solubility-permeability interplay and oral drug formulation design: Two heads are better than one.

A Dahan, A Beig, D Lindley, JM Miller - Advanced Drug Delivery …, 2016 - europepmc.org
Poor aqueous solubility is a major challenge in today's biopharmaceutics. While solubility-
enabling formulations can significantly increase the apparent solubility of the drug, the …